688566 Stock Overview
A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Jiangsu Jibeier Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.35 |
| 52 Week High | CN¥32.41 |
| 52 Week Low | CN¥17.49 |
| Beta | 0.42 |
| 1 Month Change | -8.06% |
| 3 Month Change | -9.44% |
| 1 Year Change | -28.80% |
| 3 Year Change | -2.06% |
| 5 Year Change | n/a |
| Change since IPO | -51.09% |
Recent News & Updates
Jiangsu Jibeier Pharmaceutical's (SHSE:688566) Solid Earnings May Rest On Weak Foundations
Nov 06
Even With A 38% Surge, Cautious Investors Are Not Rewarding Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Performance Completely
Oct 08Does Jiangsu Jibeier Pharmaceutical (SHSE:688566) Deserve A Spot On Your Watchlist?
Oct 01Recent updates
Jiangsu Jibeier Pharmaceutical's (SHSE:688566) Solid Earnings May Rest On Weak Foundations
Nov 06Even With A 38% Surge, Cautious Investors Are Not Rewarding Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Performance Completely
Oct 08Does Jiangsu Jibeier Pharmaceutical (SHSE:688566) Deserve A Spot On Your Watchlist?
Oct 01Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Shares Lagging The Market But So Is The Business
Jul 30Impressive Earnings May Not Tell The Whole Story For Jiangsu Jibeier Pharmaceutical (SHSE:688566)
May 02Shareholder Returns
| 688566 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -10.5% | -1.9% | -0.6% |
| 1Y | -28.8% | -5.7% | 8.3% |
Return vs Industry: 688566 underperformed the CN Pharmaceuticals industry which returned -5.7% over the past year.
Return vs Market: 688566 underperformed the CN Market which returned 8.3% over the past year.
Price Volatility
| 688566 volatility | |
|---|---|
| 688566 Average Weekly Movement | 8.0% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.9% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688566 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688566's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,295 | Zhongyi Geng | www.jbepharm.com |
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs. The company’s products cover various therapeutic areas, such as improving white blood cells, anti-hypertension, enhancing immunity, treating joint diseases, anti-eye infection, treating bronchitis, protecting liver function, and other therapeutic fields. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases.
Jiangsu Jibeier Pharmaceutical Co., Ltd. Fundamentals Summary
| 688566 fundamental statistics | |
|---|---|
| Market cap | CN¥4.46b |
| Earnings (TTM) | CN¥238.58m |
| Revenue (TTM) | CN¥887.17m |
18.7x
P/E Ratio5.0x
P/S RatioIs 688566 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688566 income statement (TTM) | |
|---|---|
| Revenue | CN¥887.17m |
| Cost of Revenue | CN¥96.07m |
| Gross Profit | CN¥791.10m |
| Other Expenses | CN¥552.52m |
| Earnings | CN¥238.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 15, 2025
| Earnings per share (EPS) | 1.20 |
| Gross Margin | 89.17% |
| Net Profit Margin | 26.89% |
| Debt/Equity Ratio | 0.1% |
How did 688566 perform over the long term?
See historical performance and comparisonDividends
2.3%
Current Dividend Yield42%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 16:25 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Jibeier Pharmaceutical Co., Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Song Yang | Tianfeng Securities Brokerage Co., Ltd |
| Tielin Chen | Topsperity Securities |
| Xinming Zhou | Topsperity Securities |